Annual SG&A
$75.54 M
+$14.25 M+23.25%
31 December 2023
Summary:
Day One Biopharmaceuticals annual selling, general & administrative expenses is currently $75.54 million, with the most recent change of +$14.25 million (+23.25%) on 31 December 2023. During the last 3 years, it has risen by +$70.86 million (+1513.48%). DAWN annual SG&A is now at all-time high.DAWN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$28.97 M
-$1.21 M-4.02%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly selling, general & administrative expenses is currently $28.97 million, with the most recent change of -$1.21 million (-4.02%) on 30 September 2024. Over the past year, it has increased by +$10.70 million (+58.53%). DAWN quarterly SG&A is now -4.02% below its all-time high of $30.19 million, reached on 30 June 2024.DAWN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.99 B
-$84.29 M-4.42%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM selling, general & administrative expenses is currently -$1.99 billion, with the most recent change of -$84.29 million (-4.42%) on 30 September 2024. Over the past year, it has dropped by -$2.06 billion (-2943.71%). DAWN TTM SG&A is now -3406.83% below its all-time high of $107.88 million, reached on 30 September 2024.DAWN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | +58.5% | -2943.7% |
| 3 y3 years | +1513.5% | +208.5% | -9895.4% |
| 5 y5 years | - | - | - |
DAWN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1513.5% | -4.0% | +208.5% | -521.5% | at low |
| 5 y | 5 years | at high | +7409.2% | -4.0% | +3485.6% | -3406.8% | at low |
| alltime | all time | at high | +7409.2% | -4.0% | +3485.6% | -3406.8% | at low |
Day One Biopharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $28.97 M(-4.0%) | $107.88 M(+11.0%) |
| June 2024 | - | $30.19 M(+13.7%) | $97.19 M(+15.6%) |
| Mar 2024 | - | $26.56 M(+19.8%) | $84.07 M(+11.3%) |
| Dec 2023 | $75.54 M(+23.3%) | $22.17 M(+21.3%) | $75.54 M(+7.8%) |
| Sept 2023 | - | $18.27 M(+7.0%) | $70.10 M(+0.9%) |
| June 2023 | - | $17.07 M(-5.3%) | $69.49 M(+4.4%) |
| Mar 2023 | - | $18.03 M(+7.8%) | $66.57 M(+8.6%) |
| Dec 2022 | $61.29 M | $16.72 M(-5.3%) | $61.29 M(+10.7%) |
| Sept 2022 | - | $17.66 M(+24.8%) | $55.35 M(+17.6%) |
| June 2022 | - | $14.16 M(+11.1%) | $47.08 M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $12.74 M(+18.2%) | $38.45 M(+31.9%) |
| Dec 2021 | $29.16 M(+522.8%) | $10.79 M(+14.8%) | $29.16 M(+43.3%) |
| Sept 2021 | - | $9.39 M(+70.0%) | $20.35 M(+69.8%) |
| June 2021 | - | $5.53 M(+60.0%) | $11.98 M(+63.5%) |
| Mar 2021 | - | $3.45 M(+74.5%) | $7.33 M(+56.5%) |
| Dec 2020 | $4.68 M(+365.4%) | $1.98 M(+93.3%) | $4.68 M(+73.2%) |
| Sept 2020 | - | $1.02 M(+17.4%) | $2.70 M(+61.0%) |
| June 2020 | - | $872.00 K(+7.9%) | $1.68 M(+107.9%) |
| Mar 2020 | - | $808.00 K | $808.00 K |
| Dec 2019 | $1.01 M | - | - |
FAQ
- What is Day One Biopharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual SG&A year-on-year change?
- What is Day One Biopharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly SG&A year-on-year change?
- What is Day One Biopharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM SG&A year-on-year change?
What is Day One Biopharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of DAWN is $75.54 M
What is the all time high annual SG&A for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual selling, general & administrative expenses is $75.54 M
What is Day One Biopharmaceuticals annual SG&A year-on-year change?
Over the past year, DAWN annual selling, general & administrative expenses has changed by +$14.25 M (+23.25%)
What is Day One Biopharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of DAWN is $28.97 M
What is the all time high quarterly SG&A for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly selling, general & administrative expenses is $30.19 M
What is Day One Biopharmaceuticals quarterly SG&A year-on-year change?
Over the past year, DAWN quarterly selling, general & administrative expenses has changed by +$10.70 M (+58.53%)
What is Day One Biopharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of DAWN is -$1.99 B
What is the all time high TTM SG&A for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM selling, general & administrative expenses is $107.88 M
What is Day One Biopharmaceuticals TTM SG&A year-on-year change?
Over the past year, DAWN TTM selling, general & administrative expenses has changed by -$2.06 B (-2943.71%)